Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival

CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses

(2017) Yasuhiro Sakai et al.   HUMAN PATHOLOGY

Whole-genome landscape of pancreatic neuroendocrine tumours

(2017) Aldo Scarpa et al.   NATURE

Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival

(2016) Joo Young Kim et al.   CLINICAL CANCER RESEARCH

Islet Cell Tumors of the Pancreas

(2016) Sunil Amin et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Clinicopathologic and Prognostic Significance of Multiple Hormone Expression in Pancreatic Neuroendocrine Tumors

(2015) Joo Young Kim et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms

(2015) Olca Basturk et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Neuroendocrine Tumors, Version 1.2015

(2015) Matthew H. Kulke et al.   Journal of the National Comprehensive Cancer Network

Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma

(2015) Hyo Jeong Kang et al.   VIRCHOWS ARCHIV

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

(2015) Paul C. McDonald et al.   Oncotarget

Alternative Lengthening of Telomeres Predicts Site of Origin in Neuroendocrine Tumor Liver Metastases

(2014) Epameinondas Dogeas et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma

(2014) Jonathan M. Bernstein et al.   LARYNGOSCOPE

Epithelial-Mesenchymal Transition Markers in the Differential Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors

(2013) Jose A. Galván et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Comparison of WHO Classifications (2004, 2010), the Hochwald Grading System, and AJCC and ENETS Staging Systems in Predicting Prognosis in Locoregional Well-differentiated Pancreatic Neuroendocrine Tumors

(2013) Ta-Chiang Liu et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype

(2013) Peeter Karihtala et al.   BREAST CANCER RESEARCH AND TREATMENT

Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors

(2013) Ilaria Marinoni et al.   GASTROENTEROLOGY

Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas

(2013) Maryline Dauphin et al.   LUNG CANCER

Expression of CK19 and KIT in resectable pancreatic neuroendocrine tumors

(2013) Xu Han et al.   TUMOR BIOLOGY

Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors

(2012) Shinichi Yachida et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System

(2012) Laura H. Tang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients

(2012) D. Speisky et al.   CLINICAL CANCER RESEARCH

Loss of PTEN Expression in Neuroendocrine Pancreatic Tumors

(2011) M. Krausch et al.   HORMONE AND METABOLIC RESEARCH

Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion

(2011) H.-J. Shin et al.   JOURNAL OF CELL SCIENCE

Prognostic Validity of a Novel American Joint Committee on Cancer Staging Classification for Pancreatic Neuroendocrine Tumors

(2011) Jonathan R. Strosberg et al.   JOURNAL OF CLINICAL ONCOLOGY

The Expression of the Hypoxia Markers CA9 and CXCR4 Is Correlated with Survival in Patients with Neuroendocrine Tumours of the Ileum

(2011) Lydia Deschamps et al.   NEUROENDOCRINOLOGY

Vimentin expression is associated with decreased survival in gastric cancer

(2011) Inokuchi   ONCOLOGY REPORTS

Altered Telomeres in Tumors with ATRX and DAXX Mutations

(2011) C. M. Heaphy et al.   SCIENCE

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

(2011) Y. Jiao et al.   SCIENCE

Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors

(2010) Dermot O'Toole et al.   ENDOCRINE-RELATED CANCER

KIT is an Independent Prognostic Marker for Pancreatic Endocrine Tumors

(2009) Lizhi Zhang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors

(2009) Karl Y. Bilimoria et al.   ANNALS OF SURGERY

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

(2008) T. R. Halfdanarson et al.   ANNALS OF ONCOLOGY

Carbonic anhydrase IX in oligodendroglial brain tumors

(2008) Sally Järvelä et al.   BMC CANCER

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas

(2008) L. Fischer et al.   BRITISH JOURNAL OF SURGERY